Agency Information Collection Activities; Proposed eCollection eComments Requested; Special Agent Medical Preplacement-ATF Form 2300.10, 22444-22445 [2020-08509]
Download as PDF
khammond on DSKJM1Z7X2PROD with NOTICES
22444
Federal Register / Vol. 85, No. 78 / Wednesday, April 22, 2020 / Notices
to the ’397 and ’721 patents, and
contingently petitioned for review of the
final ID with respect to the ’818 patent.
PTS did not file a petition for review,
and, on June 25, 2019, PTS filed a
response to ACON’s petition.
On August 13, 2019, the Commission
determined to review the Final ID in
part. Specifically, the Commission
determined to review the following
issues: (1) Whether ACON Labs’ use of
the accused products in the United
States constitutes a violation of 19
U.S.C. 1337(a)(1)(B)(i); (2) the final ID’s
construction of ‘‘reacting HDL . . .
without precipitating said one or more
non-selected analytes’’ in the ’721
patent, as well as related findings on
infringement, the domestic industry,
and invalidity; and (3) the final ID’s
finding that all of the asserted claims of
the ’721 patent are not shown to be
invalid for a lack of enablement. The
Commission did not review any other
findings presented in the final ID.
The Commission also sought briefing
from the parties on four issues and on
remedy, bonding, and public interest.
On August 27, 2019, PTS and ACON
filed their initial submissions in
response to the Commission’s request
for briefing. On September 3, 2019, PTS
and ACON filed their reply submissions
in response to the Commission’s request
for briefing. No third-party submissions
on remedy, bonding, or the public
interest were received.
Having examined the record of this
investigation, including the Final ID, the
petition, response, and other
submissions from the parties, the
Commission has determined that PTS
has shown a violation of section 337 by
ACON Bio and ACON Labs with respect
to the ’397 and ’721 patents. The
Commission has also determined to
construe the term ‘‘precipitating’’ to
mean ‘‘separating a solid substance or
material from a solution by a chemical
reaction,’’ and finds that, under this
construction, PTS established
infringement and the domestic industry
requirement with respect to claims 1, 4,
6, 8, and 15 of the ’721 patent, and that
ACON failed to show that any claim is
invalid by clear and convincing
evidence. The Commission’s
determinations are explained more fully
in the accompanying Opinion. All other
findings in the ID under review that are
consistent with the Commission’s
determinations are affirmed.
The Commission has determined that
the appropriate form of relief in this
investigation is a limited exclusion
order with respect to ACON Bio and
ACON Labs prohibiting the importation
of imported blood cholesterol testing
strips and associated systems containing
VerDate Sep<11>2014
17:59 Apr 21, 2020
Jkt 250001
the same that are covered by one or
more of claim 19 of the ’397 patent and
claims 1, 4, 6, 8, and 15 of the ’721
patent. The Commission has further
determined that the public interest
factors enumerated in subsection
337(d)(1) (19 U.S.C. 1337(d)(1)) do not
preclude the issuance of the limited
exclusion order. Finally, the
Commission has determined that the
bond for importation during the period
of Presidential review shall be in the
amount of zero percent of the entered
value of such articles.
The Commission’s notice, order, and
opinion were delivered to the President
and to the United States Trade
Representative on the day of their
issuance. The Commission has also
notified the Secretary of the Treasury
and Customs and Border Protection of
the order. The investigation is hereby
terminated.
The authority for the Commission’s
determination is contained in section
337 of the Tariff Act of 1930, as
amended (19 U.S.C. 1337), and in part
210 of the Commission’s Rules of
Practice and Procedure (19 CFR part
210).
By order of the Commission.
Issued: April 16, 2020.
Lisa Barton,
Secretary to the Commission.
[FR Doc. 2020–08480 Filed 4–21–20; 8:45 am]
BILLING CODE 7020–02–P
DEPARTMENT OF JUSTICE
recommendations for the proposed
information collection should be sent
within 30 days of publication of this
notice to www.reginfo.gov/public/do/
PRAMain. Find this particular
information collection by selecting
‘‘Currently under 30-day Review—Open
for Public Comments’’ or by using the
search function.
SUPPLEMENTARY INFORMATION: Written
comments and suggestions from the
public and affected agencies concerning
the proposed collection of information
are encouraged. Your comments should
address one or more of the following
four points:
—Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
—Evaluate the accuracy of the agency’s
estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
—Evaluate whether and if so how the
quality, utility, and clarity of the
information to be collected can be
enhanced; and
—Minimize the burden of the collection
of information on those who are to
respond, including through the use of
appropriate automated, electronic,
mechanical, or other technological
collection techniques or other forms
of information technology, e.g.,
permitting electronic submission of
responses.
Bureau of Alcohol, Tobacco, Firearms
and Explosives
Overview of This Information
Collection
[OMB Number 1140–0056]
(1) Type of Information Collection:
Revision of a currently approved
collection.
(2) The Title of the Form/Collection:
Special Agent Medical Preplacement.
(3) The agency form number, if any,
and the applicable component of the
Department sponsoring the collection:
Form number: ATF Form 2300.10.
Component: Bureau of Alcohol,
Tobacco, Firearms and Explosives, U.S.
Department of Justice.
(4) Affected public who will be asked
or required to respond, as well as a brief
abstract:
Primary: Individuals or households.
Other: Federal Government.
Abstract: The Special Agent Medical
Preplacement Form—ATF Form 2300.10
is used to collect specific personally
identifiable information (PII), including
the name, address, telephone, social
security number and certain medical
data. The collected medical data is used
to determine if a candidate is medically
Agency Information Collection
Activities; Proposed eCollection
eComments Requested; Special Agent
Medical Preplacement—ATF Form
2300.10
Bureau of Alcohol, Tobacco,
Firearms and Explosives, Department of
Justice.
ACTION: 30-Day notice.
AGENCY:
The Department of Justice
(DOJ), Bureau of Alcohol, Tobacco,
Firearms and Explosives (ATF), will
submit the following information
collection request to the Office of
Management and Budget (OMB) for
review and approval in accordance with
the Paperwork Reduction Act of 1995.
DATES: Comments are encouraged and
will be accepted for an additional 30
days until May 22, 2020.
FOR FURTHER INFORMATION CONTACT:
Written comments and
SUMMARY:
PO 00000
Frm 00052
Fmt 4703
Sfmt 4703
E:\FR\FM\22APN1.SGM
22APN1
Federal Register / Vol. 85, No. 78 / Wednesday, April 22, 2020 / Notices
qualified for and can be hired to serve
as a criminal investigator (special agent)
or an explosives enforcement officer.
(5) An estimate of the total number of
respondents and the amount of time
estimated for an average respondent to
respond: An estimated 288 respondents
will utilize the form annually, and it
will each respondents approximately 45
minutes for all respondents to prepare
their responses.
(6) An estimate of the total public
burden (in hours) associated with the
collection: The estimated annual public
burden associated with this collection is
216 hours, which is equal to 288 (# of
respondents) * 1 (number or responses
per respondents) * .75 (45 minutes).
(7) An Explanation of the Change in
Estimates: The adjustments associated
with this collection include an increase
in both the number of respondents and
total burden hours by 168 and 126 hours
respectively, since the last renewal in
2017. Due to more respondents and an
increase in the postal rate, the public
cost has also increased by $2,160, since
2017.
If additional information is required
contact: Melody Braswell, Department
Clearance Officer, United States
Department of Justice, Justice
Management Division, Policy and
Planning Staff, Two Constitution
Square, 145 N Street NE, 3E.405A,
Washington, DC 20530.
Dated: April 17, 2020.
Melody Braswell,
Department Clearance Officer for PRA, U.S.
Department of Justice.
[FR Doc. 2020–08509 Filed 4–21–20; 8:45 am]
BILLING CODE 4410–14–P
DEPARTMENT OF JUSTICE
Foreign Claims Settlement
Commission
[F.C.S.C. Meeting and Hearing Notice No.
03–20]
khammond on DSKJM1Z7X2PROD with NOTICES
Sunshine Act Meeting
The Foreign Claims Settlement
Commission, pursuant to its regulations
(45 CFR part 503.25) and the
Government in the Sunshine Act (5
U.S.C. 552b), hereby gives notice in
regard to the scheduling of open
meetings as follows:
TIME AND DATE: Thursday, April 30,
2020, at 10:00 a.m.
PLACE: This meeting will be held by
teleconference. There will be no
physical meeting place.
STATUS: Open. Members of the public
who wish to observe the meeting via
teleconference should contact Patricia
VerDate Sep<11>2014
17:59 Apr 21, 2020
Jkt 250001
M. Hall, Foreign Claims Settlement
Commission, Tele: (202) 616–6975, two
business days in advance of the
meeting. Individuals will be given callin information upon notice of
attendance to the Commission.
MATTERS TO BE CONSIDERED: 10:00
a.m.—Issuance of Proposed Decisions
under the Guam World War II Loyalty
Recognition Act, Title XVII, Public Law
114–328.
CONTACT PERSON FOR MORE INFORMATION:
Requests for information, advance
notices of intention to observe an open
meeting, and requests for teleconference
dial-in information may be directed to:
Patricia M. Hall, Foreign Claims
Settlement Commission, 441 G St. NW,
Room 6234, Washington, DC 20579.
Telephone: (202) 616–6975.
Brian M. Simkin,
Chief Counsel.
[FR Doc. 2020–08585 Filed 4–20–20; 11:15 am]
BILLING CODE 4410–BA–P
DEPARTMENT OF JUSTICE
[OMB Number 1122–0003]
Agency Information Collection
Activities; Proposed eCollection
eComments Requested; Extension of a
Currently Approved Collection
Office on Violence Against
Women, Department of Justice.
ACTION: 30-Day notice.
AGENCY:
The Department of Justice,
Office on Violence Against Women
(OVW) will be submitting the following
information collection request to the
Office of Management and Budget
(OMB) for review and approval in
accordance with the Paperwork
Reduction Act of 1995.
DATES: Comments are encouraged and
will be accepted for 30 days until May
22, 2020.
FOR FURTHER INFORMATION CONTACT:
Written comments and
recommendations for the proposed
information collection should be sent
within 30 days of publication of this
notice to www.reginfo.gov/public/do/
PRAMain. Find this particular
information collection by selecting
‘‘Currently under 30-day Review—Open
for Public Comments’’ or by using the
search function.
SUPPLEMENTARY INFORMATION: Written
comments and suggestions from the
public and affected agencies concerning
the proposed collection of information
are encouraged. Your comments should
address one or more of the following
four points:
SUMMARY:
PO 00000
Frm 00053
Fmt 4703
Sfmt 4703
22445
(1) Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
(2) Evaluate the accuracy of the
agency’s estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
(3) Enhance the quality, utility, and
clarity of the information to be
collected; and
(4) Minimize the burden of the
collection of information on those who
are to respond, including through the
use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submission of
responses.
Overview of This Information
Collection
(1) Type of Information Collection:
Extension of a currently approved
collection.
(2) Title of the Form/Collection:
Annual Progress Report for the STOP
Formula Grants Program.
(3) Agency form number, if any, and
the applicable component of the
Department of Justice sponsoring the
collection: Form Number: 1122–0003.
U.S. Department of Justice, Office on
Violence Against Women.
(4) Affected public who will be asked
or required to respond, as well as a brief
abstract: The affected public includes
the 56 STOP state administrators (from
50 states, the District of Columbia and
five territories and commonwealths
(Guam, Puerto Rico, American Samoa,
Virgin Islands, Northern Mariana
Islands)) and their subgrantees. The
STOP Violence Against Women
Formula Grants Program was authorized
through the Violence Against Women
Act of 1994 (VAWA) and reauthorized
and amended by the Violence Against
Women Act of 2000 (VAWA 2000) and
by the Violence Against Women Act of
2005 (VAWA 2005). Its purpose is to
promote a coordinated, multidisciplinary approach to improving the
criminal justice system’s response to
violence against women. The STOP
Formula Grants Program envisions a
partnership among law enforcement,
prosecution, courts, and victim
advocacy organizations to enhance
victim safety and hold offenders
accountable for their crimes of violence
against women. OVW administers the
STOP Formula Grants Program. The
grant funds must be distributed by
STOP state administrators to
E:\FR\FM\22APN1.SGM
22APN1
Agencies
[Federal Register Volume 85, Number 78 (Wednesday, April 22, 2020)]
[Notices]
[Pages 22444-22445]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-08509]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Bureau of Alcohol, Tobacco, Firearms and Explosives
[OMB Number 1140-0056]
Agency Information Collection Activities; Proposed eCollection
eComments Requested; Special Agent Medical Preplacement--ATF Form
2300.10
AGENCY: Bureau of Alcohol, Tobacco, Firearms and Explosives, Department
of Justice.
ACTION: 30-Day notice.
-----------------------------------------------------------------------
SUMMARY: The Department of Justice (DOJ), Bureau of Alcohol, Tobacco,
Firearms and Explosives (ATF), will submit the following information
collection request to the Office of Management and Budget (OMB) for
review and approval in accordance with the Paperwork Reduction Act of
1995.
DATES: Comments are encouraged and will be accepted for an additional
30 days until May 22, 2020.
FOR FURTHER INFORMATION CONTACT: Written comments and recommendations
for the proposed information collection should be sent within 30 days
of publication of this notice to www.reginfo.gov/public/do/PRAMain.
Find this particular information collection by selecting ``Currently
under 30-day Review--Open for Public Comments'' or by using the search
function.
SUPPLEMENTARY INFORMATION: Written comments and suggestions from the
public and affected agencies concerning the proposed collection of
information are encouraged. Your comments should address one or more of
the following four points:
--Evaluate whether the proposed collection of information is necessary
for the proper performance of the functions of the agency, including
whether the information will have practical utility;
--Evaluate the accuracy of the agency's estimate of the burden of the
proposed collection of information, including the validity of the
methodology and assumptions used;
--Evaluate whether and if so how the quality, utility, and clarity of
the information to be collected can be enhanced; and
--Minimize the burden of the collection of information on those who are
to respond, including through the use of appropriate automated,
electronic, mechanical, or other technological collection techniques or
other forms of information technology, e.g., permitting electronic
submission of responses.
Overview of This Information Collection
(1) Type of Information Collection: Revision of a currently
approved collection.
(2) The Title of the Form/Collection: Special Agent Medical
Preplacement.
(3) The agency form number, if any, and the applicable component of
the Department sponsoring the collection:
Form number: ATF Form 2300.10.
Component: Bureau of Alcohol, Tobacco, Firearms and Explosives,
U.S. Department of Justice.
(4) Affected public who will be asked or required to respond, as
well as a brief abstract:
Primary: Individuals or households.
Other: Federal Government.
Abstract: The Special Agent Medical Preplacement Form--ATF Form
2300.10 is used to collect specific personally identifiable information
(PII), including the name, address, telephone, social security number
and certain medical data. The collected medical data is used to
determine if a candidate is medically
[[Page 22445]]
qualified for and can be hired to serve as a criminal investigator
(special agent) or an explosives enforcement officer.
(5) An estimate of the total number of respondents and the amount
of time estimated for an average respondent to respond: An estimated
288 respondents will utilize the form annually, and it will each
respondents approximately 45 minutes for all respondents to prepare
their responses.
(6) An estimate of the total public burden (in hours) associated
with the collection: The estimated annual public burden associated with
this collection is 216 hours, which is equal to 288 (# of respondents)
* 1 (number or responses per respondents) * .75 (45 minutes).
(7) An Explanation of the Change in Estimates: The adjustments
associated with this collection include an increase in both the number
of respondents and total burden hours by 168 and 126 hours
respectively, since the last renewal in 2017. Due to more respondents
and an increase in the postal rate, the public cost has also increased
by $2,160, since 2017.
If additional information is required contact: Melody Braswell,
Department Clearance Officer, United States Department of Justice,
Justice Management Division, Policy and Planning Staff, Two
Constitution Square, 145 N Street NE, 3E.405A, Washington, DC 20530.
Dated: April 17, 2020.
Melody Braswell,
Department Clearance Officer for PRA, U.S. Department of Justice.
[FR Doc. 2020-08509 Filed 4-21-20; 8:45 am]
BILLING CODE 4410-14-P